Ben Greenblum focuses on commercial and complex civil litigation. He has tried cases in court and in arbitration. His practice is national in scope, and he has represented both plaintiffs and defendants in high-dollar disputes.
Ben has experience in a range of substantive areas, including antitrust law, food and drug law, contract disputes, intellectual property, securities law, and class actions. He has represented individuals, pharmaceutical companies, property management firms, energy firms, manufacturers, and defense contractors, among other clients. Ben was selected as a “Rising Star” in the 2014 through 2017 Washington, D.C. editions of Super Lawyers.
In 2017, Ben co-authored a chapter titled “The Philosophy of Food and Drug Law” in the Food & Drug Law Institute’s A Practical Guide to FDA’s Food & Drug Law and Regulation, Sixth Edition.
A native of Washington, D.C., Ben graduated summa cum laude with both a B.S. from the Wharton School and a B.A. from the College of Arts & Sciences at the University of Pennsylvania in 2001. He earned a J.D. from Columbia Law School in 2006, where he was a James Kent Scholar and an editor of the Columbia Law Review. He joined the firm in 2007 after clerking for the Honorable Dennis Jacobs, Chief Judge, United States Court of Appeals for the Second Circuit.
- Represented several pharmaceutical companies in antitrust litigation, including in first of its kind multi-million dollar antitrust jury trial
- Represented pharmaceutical firms in contract disputes regarding intellectual property and joint venture agreements
- Represented clients in regulatory investigations and class action disputes over alleged unfair trade practices
- Represented multinational bank in litigations arising from complex securitized products
- Represented large energy concern in multi-million dollar arbitrations
- Represented national property manager in contract litigation with REIT
Last updated October 2018